Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Charlotte Romanet et al.|Circulation|2025Cited by 26
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Identification of integrin a5b1 inhibition as a potentially disease-modifying approach for the treatment of pulmonary arterial hypertensionMónica S. Montesinos, Min Lü, Sarah‐Eve Lemay et al.|Unknown|2024Cited by 0